Commentary: States Must Act Now to Save Rural Lives from Fentanyl Crisis

Heidi Heitkamp

Across rural America, the expanding crisis of fentanyl-fueled overdoses is ravaging a generation. According to the Centers for Disease Control and Prevention, fentanyl deaths in the U.S. have tripled since 2016, and initial data from 2022 indicates that synthetic opioids cause about 90% of all opioid overdose deaths – which translates to nearly 75,000 Americans killed in that year alone. Rural communities, where hundreds of hospitals have already closed and more are on the chopping block, are bearing the additional weight of overdoses. We need states to do more to protect Americans and ensure access to all overdose reversal agents that have been approved by the U.S. Food and Drug Administration. 

According to the U.S. Drug Enforcement Administration, fentanyl is 50 times stronger than heroin and 100 times stronger than morphine. Hidden in counterfeit prescription pharmaceuticals like Adderall, Xanax, and Oxycontin, it’s so lethal that just two milligrams, the size of a pencil tip, can kill. 

Read the full story

PR Group Behind ‘Watchdog’ NewsGuard Hit with $350 Million Settlement over OxyContin Marketing

French public and advertising giant Publicis Groupe — the lead funder of  “disinformation watchdog” NewsGuard — has agreed to pay $350 million as part of a settlement with state attorneys general over the company’s role in America’s opioid crisis. “Today’s filings describe how Publicis’ work contributed to the crisis by helping Purdue Pharma and other opioid manufacturers market and sell opioids,” said a press release from South Carolina Attorney General Alan Wilson. “Court documents detail how Publicis acted as Purdue’s agency of record for all its branded opioid drugs, including OxyContin, even developing sales tactics that relied on farming data from recordings of personal health-related in-office conversations between patients and providers.” “The company was also instrumental in Purdue’s decision to market OxyContin to providers on patient’s electronic health records,” said the press release. At the same time it is paying this $350 million settlement over its marketing tactics — Publicis Groupe, headed by CEO and Chairman Arthur Sadoun (pictured above) is also the “largest corporate investor” in NewsGuard, a company whose co-founder said it is a “vaccine against misinformation,” reported Lee Fang in RealClearInvestigations. NewsGuard said it “provides transparent tools to counter misinformation” and in 2021, it announced a partnership with Publicis to “combat…

Read the full story

Virginia Expects $60 Million in Tentative Opioid Crisis Settlement with Walmart

Virginia is expected to receive $60 million as part of a tentative $3.1 billion settlement agreement with Walmart after allegations of insufficient oversight of opioid dispensing at the chain’s pharmacies.

“Companies who facilitated the dispensing of opioids contributed to the opioid epidemic that has devastated millions of lives. This significant settlement will help us fight back against the epidemic and provide abatement and rehabilitation resources to suffering Virginians,” Attorney General Jason Miyares said in a press release.

Read the full story

Drug Enforcement Administration Issues First Public Safety Alert in over Half a Decade After Surges in Illicit Fentanyl

Fentanyl

The Drug Enforcement Administration (DEA) issued a Public Safety Alert Monday warning of the surge in illegal fake painkillers combined with illicit fentanyl or methamphetamine.

The Public Safety Alert, the first warning in six years, highlighted the surge in fentanyl and methamphetamine-laced pills mass produced by criminal drug groups, which are killing Americans at a historic rate, according to a DEA press release.

“The United States is facing an unprecedented crisis of overdose deaths fueled by illegally manufactured fentanyl and methamphetamine,” Anne Milgram, administrator of the DEA, said in the press release.

Read the full story

Fairfax ‘Pill Mill’ Doctor Gets Seven Years

U.S. District Judge Leonie M. Brinkema sentenced Fairfax doctor Felicia Donald to seven years in prison for operating a “pill mill” at For Women OB/GYN Associates and NOVA Addiction Center. According to a Department of Justice press release, from April 2016 to April 2020 Donald distributed over $1.2 million worth of oxycodone and other controlled substances. Donald pled guilty on May 4, 2020.

Read the full story

OxyContin Maker Purdue Pharma to Plead to Three Criminal Charges

Purdue Pharma, the company that makes OxyContin, the powerful prescription painkiller that experts say helped touch off an opioid epidemic, will plead guilty to three federal criminal charges as part of a settlement of more than $8 billion, Justice Department officials announced Wednesday.

The company will plead guilty to three counts, including conspiracy to defraud the United States and violating federal anti-kickback laws, the officials said. The resolution will be detailed in a bankruptcy court filing in federal court.

Read the full story

Experts: Revamped OxyContin Hasn’t Curbed Abuse, Overdoses

A panel of government health advisers said Friday there’s no clear evidence that a harder-to-crush version of the painkiller OxyContin designed to discourage abuse actually resulted in fewer overdoses or deaths.

The conclusion from the Food and Drug Administration advisory panel comes more than a decade after Purdue Pharma revamped its blockbuster opioid, which has long been blamed for sparking a surge in painkiller abuse beginning in the 1990s.

Read the full story

Maker of OxyContin Agrees to $270M Settlement in Oklahoma

The maker of OxyContin and the company’s controlling family agreed Tuesday to pay a groundbreaking $270 million to Oklahoma to settle allegations they helped create the nation’s deadly opioid crisis with their aggressive marketing of the powerful painkiller. It is the first settlement to come out of the recent coast-to-coast wave of nearly 2,000 lawsuits against Purdue Pharma that threaten to push the company into bankruptcy and have stained the name of the Sackler family, whose members rank among the world’s foremost philanthropists. “The addiction crisis facing our state and nation is a clear and present danger, but we’re doing something about it today,” Oklahoma Attorney General Mike Hunter said. Nearly $200 million will go toward establishing a National Center for Addiction Studies and Treatment at Oklahoma State University in Tulsa, while local governments will get $12.5 million. The Sacklers are responsible for $75 million of the settlement. In settling, the Stamford, Connecticut-based company denied any wrongdoing in connection with what Hunter called “this nightmarish epidemic” and “the worst public health crisis in our state and nation we’ve ever seen.” The deal comes two months before Oklahoma’s 2017 lawsuit against Purdue Pharma and other drug companies was set to become…

Read the full story

OxyContin Makers’ Opioid Trial to Begin on Schedule

OxyContin maker Purdue Pharma LP and two other drugmakers Friday lost a bid to delay a landmark trial set for May in a multibillion-dollar lawsuit by Oklahoma’s attorney general accusing them of helping fuel an opioid abuse and overdose epidemic in the state. Cleveland County District Judge Thad Balkman’s decision was a win for the state, even as one of the lawyers for the state said Purdue had threatened to file for bankruptcy rather than face the first trial to result from around 2,000 lawsuits nationally. “This case needs to get to trial because people are dying every day,” Reggie Whitten, the lawyer for the state, said during a hearing in Norman, Oklahoma. Bankruptcy threat Reuters, citing people familiar with the matter, Monday reported that Stamford, Connecticut-based Purdue, owned by members of the wealthy Sackler family, was exploring filing for Chapter 11 bankruptcy protection. Doing so would allow it to address potential legal liabilities while halting the cases. Eric Pinker, Purdue’s lawyer, made no mention of a potential bankruptcy while arguing that the May 28 trial in the lawsuit brought by Oklahoma Attorney General Mike Hunter against it, Johnson & Johnson and Teva Pharmaceutical Industries Ltd should be delayed. He…

Read the full story

New Info About Opioid-Profiteering Family Pushes Largest Museum in US to Rethink Gift Acceptance Policies

by Evie Fordham   The Metropolitan Museum of Art is reviewing its gift acceptance policies after information that members of a prominent donor family headed a deceit campaign to push the highly addictive prescription opioid OxyContin, The Met told The Daily Caller News Foundation. Other New York City art museums that have taken money from the Sackler family, which owns Purdue Pharma, refused to comment on the Tuesday court filing with documents showing members of the Sackler family covered up information about the dangers of OxyContin. “The Sackler family has been connected with The Met for more than a half century. The family is a large extended group and their support of The Met began decades before the opioid crisis. The Met is currently engaging in a further review of our detailed gift acceptance policies, and we will have more to report in due course,” Daniel H. Weiss, president and CEO of The Met, told TheDCNF in a statement Thursday. An employee at The Met told TheDCNF news about the Sackler family is what prompted the institution to review its policy, although the employee would not detail any review timeline. Sackler family members gave a whopping $20 million to the…

Read the full story